ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EDEN Eden Research Plc

4.35
0.05 (1.16%)
07 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 1.16% 4.35 4.20 4.50 4.35 4.30 4.30 442,218 10:40:21
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -10.36 23.2M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.30p. Over the last year, Eden Research shares have traded in a share price range of 3.65p to 12.00p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £23.20 million. Eden Research has a price to earnings ratio (PE ratio) of -10.36.

Eden Research Share Discussion Threads

Showing 6376 to 6395 of 18175 messages
Chat Pages: Latest  259  258  257  256  255  254  253  252  251  250  249  248  Older
DateSubjectAuthorDiscuss
12/4/2019
16:07
Ecological food: significant reduction in chemical exposure.



The results of one of the most significant studies published in recent months in this field have been published in the journal Environmental Research (printed edition of April 2019, available on the internet since February 12). In this scientific article, the team headed by Carly Hyland, from the Center for Environmental Research and Child Health of the School of Public Health of the University of California at Berkeley (United States), concludes that, based on the analyzes carried out, it is possible to affirm that a diet based on organic food significantly reduces the presence of various pesticides in the urine of the people studied. "This study adds to the growing body of literature that indicates that an organic diet [with organically grown food] can reduce exposure to a remarkable variety of pesticides in children and adults," the authors write.

The objective of the study was to determine if the introduction of an organic diet in people who usually eat conventional agricultural products can reduce the presence in your body of the most common insecticides, herbicides and fungicides.

To test this hypothesis, the authors analyzed 158 urine samples from 16 people from four different areas of the United States. That is to say, the urine of people was analyzed while they were fed with products of conventional agriculture and, later, the urine of these people was re-analyzed a few days after becoming consumers of organic products.

The result was that in the urine analyzed after the diet change "we observed significant reductions" in the levels of 13 metabolites (derived substances) or primary compounds of insecticides and herbicides, the authors point out.
Diet is an important part of the exposure of the general population to certain chemical substances.

The most significant decreases corresponded to the presence of clothianidin, an insecticide of the neonicotinoid family (the group of substances involved in the mass death of bees), and two metabolites of malathion (a synthetic organophosphorus insecticide widely used in agriculture) and of chlorpyrofos (an organophosphorus insecticide that some studies relate, in chronic exposure, to neurological effects and developmental and autoimmune disorders in humans).

In the introduction of this new study, the authors remind that diet is an important part of the exposure of the general population to certain chemical substances. In a previous investigation, led in 2016 by the Food and Drug Administration of the United States (FDA for its acronym in English) indicated that approximately 47% of foods made in the United States and 49% of those imported from other countries they contained pesticide residues. The control samples also made by official US agencies, including the Department of Agriculture, indicate that foods from organic farming "contain less pesticide residues compared to conventional agriculture," the authors of the paper recalled. study published now in Environmental Research.

After these basic data, the team led by Carly Hyland, mentions four previous scientific studies in which exposure to pesticides is related to various health problems; especially, a lower score in cognitive abilities, asthma, cancer and the reproductive and endocrine systems.

To finish exposing the relationship between pesticides, ecological agriculture and health, the authors remember the publication in October 2018 in the European Journal of Nutrition of a study led by Julia Baudry (researcher at the Center for Epidemiology and Statistics of the University of Paris in Bobigny) in which it is indicated that people with diets based on organic food have a low probability of presenting the so-called metabolic syndrome (group of conditions that increase the risk of developing heart disease and type 2 diabetes). The results of this latest study are based on the medical history of almost 70,000 people.

The study published now in Environmental Research is signed by six researchers from four centers of recognized scientific prestige and by Kendra Klein, member of the scientific team specialized in Agroecology and Environmental Health of the Friends of the Earth organization in the United States.

The presence of Klein in the team of authors of this study has been used by some US media and groups of scientists to try to discredit the results, although the publication in the scientific journal Environmental Research should already be a reason for recognition .

Thus, in a newspaper article published on the website of Forbes magazine (specializing in economics and large companies), Jenny Splitter harshly criticizes the scientific study published in Environmental Research. Splitter says that the researchers "have only analyzed the presence of pesticides allowed in conventional agriculture and have not [sought] the pesticides allowed in organic farming"; in a statement that seems to want to compare the use of chemicals in these two different ways of practicing agriculture.

More puzzling is the paragraph in which it is stated verbatim that "the study [of the Environmental Research magazine] does not say anything about whether there is any health risk associated with conventional pesticide residues, since the mere presence of a chemical in Urine is not necessarily an unhealthy or dangerous sign. " In this case, the comments are superfluous because it seems obvious that no one in their right mind can feel safe when ingesting and urinating synthetic pesticides.

To justify her criticism, Jenny Splitter concludes her article stating that "not all pesticides are the same" and that using or not using pesticides - natural and synthetic - in agriculture is "a complex issue", with factors for and against.

Author: Joaquim Elcacho, Journalist specialized in Environment and Science

supersonico
12/4/2019
15:07
Bio-pesticide Hockey stick fuel News

French court finds Monsanto guilty of poisoning farmer
Ruling says chemicals giant knew of weedkiller’s dangers but label lacked warning



Judge Makes Official Order for Bayer Mediation With Cancer Victims

After a week of behind-the-scenes discussions, U.S. District Judge Vince Chhabria has issued a formal order of mediation to seek a settlement between Bayer AG and lawyers representing thousands of cancer victims who are suing Monsanto alleging their exposure to the company’s Roundup herbicide caused their illnesses.

supersonico
12/4/2019
14:31
Makes me a bit ambivalent about our association with Bayer, though!
brucie5
12/4/2019
14:27
Brucie

Yes alarmingly interesting. Here is the first interview which is equally informing and alarming and why I believe the predictions for Bio product adoption is underestimated.

GMOs, Glyphosate & Gut Health

supersonico
12/4/2019
13:51
Super: re.6015

Really interesting. One application of Roundup kills 50% of earthworms. If true, I would have thought that was a criminal act right there!

Another extraordinary figure: 10 years to build 1cm of soil.

(If true!)

brucie5
12/4/2019
12:25
Bayer Direction of Travel News..Terpenes

Composition comprising a pesticidal terpene mixture and a fungicide



METHODS OF INHIBITING, PREVENTING, KILLING AND/OR REPELLING INSECTS USING SIMULATED BLENDS OF CHENOPODIUM

supersonico
12/4/2019
11:49
1 out of 2 Men will get Cancer
1 out of 3 women will get Cancer
1 in 46 children will have Chronic Health issues
1 in 3 kids will be on Autism spectrum by 2030/5

@ 13min.

I'm just waiting for the Marketing geniuses to wake up to the opportunities the Autism demographic offers and Wild Autism Pride Marches sponsored by Syngenta with front page coverage in the Dystopian Times Weekly.

supersonico
11/4/2019
22:12
In answer earlier on I take no heed of Shore.The month before they talked of mid term and patience in the Evening Standard.
Nothing at the moment tells me anything other than Medium term and sit tight. I had thought 6months ago it was Sept 19 But now I think 2020 Is the earliest date for any real good price news.
Trust well that’s a funny thing as theyve never, at least in the 3 yrs previous made any calls that have broken any trust.
I would counsel keep the lid on too many short term expectations and hope there is nothing coming up fast on the rails

chrischas
11/4/2019
17:10
I would say trust is already an issue. No new investment in the share price says so.
investingisatrickygame
11/4/2019
16:08
Chrischas,

I'm more persuaded that the commercial interests and plans of Bayer and Sumitomo possibly along with Eastman or others that we have not been told about are the 'Lid' on Eden and TT's communication issues as they both seem afflicted.

The Lid may prevent Eden communicating on all matter of issues that we have know idea about. The smoking gun is the parallel delays imo which suggests to me that either Sumitomo or Bayer is working with TT or that their is an issue pertinent/common to both that effects both independently that needs to be overcome that gives the false impression of parallel working but instead is a more deeply rooted issue.
Either way the company is telling investors that it will be resolved by Sept19.

I believe the Trust element that Eden have relied heavily upon will be tested if they don't either deliver or come clean on what the issue is that keeps these cans being kicked down the road in unison.

I'm confident this will be frustrating the management as much as investors and am confident they will be trying their level best to resolve whatever is delaying both launches. The dilemma for them is managing the Lid/NDA's with Investor expectation and keeping trust and professional reputation intact. We can only hope a resolution to this double bind is something within their gift.

My bet is it is.

supersonico
11/4/2019
13:05
If what you say is correct, why did the directors award them such huge share options at a such a relative low price, which could we worthless by September 2019 if the share price is around these levels?Surely, the directors are not in the game to micro management every minute detail? Are they?
northwick
11/4/2019
12:32
Chrischas, what did you think of the Shore note? Is this part of your thinking, too?
brucie5
11/4/2019
09:14
I’m referring to the company set up and how it is run
chrischas
11/4/2019
08:42
Chrischas ..what parts of the Eden pipeline or Vertical are you referring to?
supersonico
10/4/2019
15:23
Super said

"I'm pleased MW appears to be taking a James Finlayson double take of the Shore cap Note as it bears no resemblance to the Chairs Inflexion point statement. Either all his years at Bayer have taught him nothing or were getting told a bent Radish.

We can only hope that his Inflexion point comments are more accurate than his Short order."

I agree again. Shore Cap report issued, why? Chairman's statement(s)not aligning with the MW reported commentary from Shore Cap. Shore Cap valuation not aligning with perceived value and statements outlined by Eden generally.

Are we and our expectations wrong or does Eden need to deliver their intended report to show the true value of the business which we hope is better aligned with the Chairman and CEO commentary. And then in delivering this new report and valuation how does Eden deliver this to the investment community for acceptance vis-à-vis Shore Capital's assessment of the business. People are bound to ask which is more accurate and then question why the other was issued, that is just basic human nature for reassurance.

investingisatrickygame
10/4/2019
13:00
I'm pleased MW appears to be taking a James Finlayson double take of the Shore cap Note as it bears no resemblance to the Chairs Inflexion point statement. Either all his years at Bayer have taught him nothing or were getting told a bent Radish.

We can only hope that his Inflexion point comments are more accurate than his Short order.

supersonico
10/4/2019
12:22
Yes Brucie. his note is entitled "Dancing in the Dark". sub title as you say, "The hidden attractions of Eden."
Reminds me of Salome's dance of the seven veils......when oh when will all be revealed? "Get 'em off roar the investor hoards. And whose head will be on the line?

littlealbatross2
10/4/2019
11:22
Interesting summary on MW. His opinion piece is entitled 'the Hidden attractions of Eden', which I think just about sums up the response of many to yesterday's note: the larger parts of iceburg are not yet visible. In particular the value of Sustainea. I think we knew that.
brucie5
10/4/2019
09:52
Also with the High chance of the Bayer and TT delays being linked imo then once those dots are joined and potentially added to the Bayer 2013 opportunities this share blows up beyond anything Shore cap can realistically project.

Their is always a motive behind incongruence aka Why The Lid?

Parallel incongruent Universe;

2015..in the coming months got us to 2016
2016..in the coming months got us to 2017
2017..in the coming months got us to 2018
2018..in the coming months got us to June 2018
June 2018..in short order/ Shelf life got us to Sept 2018
Sept 2018..New school year..gets us to Jan 2019.
Jan 2019..TT New school year goes to Return to School summer 2019.
Jan 2019..Bayer formulation issue .ready Sept 2019.

Come on.. The chain is being yanked

All guesses all the Time

supersonico
10/4/2019
09:15
'Why has Eden given it and why have they given it now?'

Good question Investing especially as most of the Edenberg IP pipeline value is hidden from view atm and as such cannot be valued or commented upon. Sustaine Colaboration / Bayer 2013 / Organic market / TT collaborator detail / Sumitomo Seipro .

Any comment that is made is bound to be conservative imo because of this. Medium term I also believe that the Bio pesticide market growth predictions will prove conservative as awareness grows and the producers catch up with demand.

Add the production of this report to Eden's ramped up Proactive presence and talk of expansion and Twitter friends in the PR world at least points to an EDEN spring after years of relative PR hibernation.

supersonico
Chat Pages: Latest  259  258  257  256  255  254  253  252  251  250  249  248  Older